Verheul HMW - Search Results

1

Insight in taste alterations during treatment with protein kinase inhibitors.

van der Werf A, Rovithi M, Langius JAE, de van der Schueren MAE, Verheul HMW. van der Werf A, et al. Among authors: verheul hmw. Eur J Cancer. 2017 Nov;86:125-134. doi: 10.1016/j.ejca.2017.09.006. Epub 2017 Oct 4. Eur J Cancer. 2017. PMID: 28987769 Review.

2

Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?

Gotink KJ, Verheul HM. Gotink KJ, et al. Angiogenesis. 2010 Mar;13(1):1-14. doi: 10.1007/s10456-009-9160-6. Epub 2009 Dec 11. Angiogenesis. 2010. PMID: 20012482 Free PMC article. Review.

3

Weight loss of 5% or more predicts loss of fat-free mass during palliative chemotherapy in patients with advanced cancer: a pilot study.

Buskermolen S, Langius JA, Kruizenga HM, Ligthart-Melis GC, Heymans MW, Verheul HM. Buskermolen S, et al. Nutr Cancer. 2012 Aug;64(6):826-32. doi: 10.1080/01635581.2012.690062. Epub 2012 Jun 14. Nutr Cancer. 2012. PMID: 22697804 Clinical Trial.

4

'Pre-cachexia': a non-existing phenomenon in cancer?

Blauwhoff-Buskermolen S, de van der Schueren MA, Verheul HM, Langius JA. Blauwhoff-Buskermolen S, et al. Ann Oncol. 2014 Aug;25(8):1668-9. doi: 10.1093/annonc/mdu178. Epub 2014 May 14. Ann Oncol. 2014. PMID: 24827129 Free article. No abstract available.

5

Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib.

Gotink KJ, Rovithi M, de Haas RR, Honeywell RJ, Dekker H, Poel D, Azijli K, Peters GJ, Broxterman HJ, Verheul HM. Gotink KJ, et al. Cell Oncol (Dordr). 2015 Apr;38(2):119-29. doi: 10.1007/s13402-015-0218-8. Epub 2015 Feb 11. Cell Oncol (Dordr). 2015. PMID: 25665527 Free PMC article.

6

The effect of individualized nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: a randomized controlled trial protocol.

van der Werf A, Blauwhoff-Buskermolen S, Langius JA, Berkhof J, Verheul HM, de van der Schueren MA. van der Werf A, et al. BMC Cancer. 2015 Mar 5;15:98. doi: 10.1186/s12885-015-1092-5. BMC Cancer. 2015. PMID: 25884881 Free PMC article. Clinical Trial.

7

The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A/CS and the VAS for appetite.

Blauwhoff-Buskermolen S, Ruijgrok C, Ostelo RW, de Vet HCW, Verheul HMW, de van der Schueren MAE, Langius JAE. Blauwhoff-Buskermolen S, et al. Among authors: verheul hmw. Support Care Cancer. 2016 Feb;24(2):661-666. doi: 10.1007/s00520-015-2826-2. Epub 2015 Jul 10. Support Care Cancer. 2016. PMID: 26160463 Free PMC article.

8

Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer.

Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA, den Braver NR, Berkhof J, Langius JA, Verheul HM. Blauwhoff-Buskermolen S, et al. J Clin Oncol. 2016 Apr 20;34(12):1339-44. doi: 10.1200/JCO.2015.63.6043. Epub 2016 Feb 22. J Clin Oncol. 2016. PMID: 26903572

9

Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer.

Rovithi M, Lind JS, Pham TV, Voortman J, Knol JC, Verheul HM, Smit EF, Jimenez CR. Rovithi M, et al. Proteomics Clin Appl. 2016 Jul;10(7):743-9. doi: 10.1002/prca.201600025. Epub 2016 May 27. Proteomics Clin Appl. 2016. PMID: 27040893 Clinical Trial.

10

Reply to L.E. Daly et al.

Blauwhoff-Buskermolen S, de van der Schueren MAE, Langius JAE, Verheul HMW. Blauwhoff-Buskermolen S, et al. Among authors: verheul hmw. J Clin Oncol. 2016 Nov 1;34(31):3817. doi: 10.1200/JCO.2016.68.9364. J Clin Oncol. 2016. PMID: 27480150 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters